Related Experiment Video
Updated: Jun 12, 2026

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Single-Strain Probiotic Lactobacilli for the Treatment of Atopic Dermatitis in Children: A Systematic Review and
Sabina Fijan1, Nina Kolč2, Metka Hrašovec2
1Faculty of Health Sciences, University of Maribor, Žitna ulica 15, 2000 Maribor, Slovenia.
Insights
Single-strain probiotic lactobacilli significantly reduced atopic dermatitis severity in children. Specific strains like Limosilactobacillus fermentum, longer treatment durations, and younger patient ages improved outcomes, highlighting the importance of tailored probiotic selection.
Area of Science:
- Microbiology and Immunology
- Pediatric Dermatology
Background:
- Probiotics influence gut microbiota and immune system development.
- Infant gut and skin colonization may impact atopic dermatitis (AD) risk.
- Evidence suggests probiotics could aid in AD prevention and treatment.
Purpose of the Study:
- To systematically review and evaluate the efficacy of single-strain probiotic lactobacilli in treating childhood atopic dermatitis.
- To identify specific probiotic strains, treatment durations, and patient ages associated with improved AD outcomes.
Main Methods:
- Systematic review and meta-analysis of 17 randomized placebo-controlled trials.
- Included trials focused on single-strain lactobacilli and the Scoring Atopic Dermatitis (SCORAD) index.
- Searches conducted in major databases (PubMed, Web of Science, etc.) until October 2022; quality assessed using Joanna Briggs Institute tools.
Main Results:
- Meta-analysis of 14 trials (1124 children) showed single-strain lactobacilli significantly reduced SCORAD index compared to placebo (MD: -4.50, p=0.003).
- Subgroup analysis indicated Limosilactobacillus fermentum strains were more effective than L. plantarum, L. paracasei, or L. rhamnosus.
- Longer treatment duration and younger patient age were associated with statistically significant symptom reduction.
Conclusions:
- Certain single-strain probiotic lactobacilli demonstrate significant efficacy in reducing atopic dermatitis severity in children.
- Strain selection (e.g., L. fermentum), treatment duration, and patient age are critical factors for optimizing probiotic therapy effectiveness.
- Targeted probiotic interventions hold promise for managing childhood atopic dermatitis.
Abstract:
Probiotics are known for their positive effects on the gut microbiota. There is growing evidence that the infant gut and skin colonization have a role in the development of the immune system, which may be helpful in the prevention and treatment of atopic dermatitis. This systematic review focused on evaluating the effect of single-strain probiotic lactobacilli consumption on treating children's atopic dermatitis. Seventeen randomized placebo-controlled trials with the primary outcome of the Scoring Atopic Dermatitis (SCORAD) index were included in the systematic review. Clinical trials using single-strain lactobacilli were included. The search was conducted until October 2022 using PubMed, ScienceDirect, Web of Science, Cochrane library and manual searches. The Joanna Briggs Institute appraisal tool was used to assess the quality of the included studies. Meta-analyses and sub meta-analyses were performed using Cochrane Collaboration methodology. Due to different methods of reporting the SCORAD index, only 14 clinical trials with 1124 children were included in the meta-analysis (574 in the single-strain probiotic lactobacilli group and 550 in the placebo group) and showed that single-strain probiotic lactobacilli statistically significantly reduced the SCORAD index compared to the placebo in children with atopic dermatitis (mean difference [MD]: -4.50; 95% confidence interval [CI]: -7.50 to -1.49; Z = 2.93; p = 0.003; heterogeneity I2 = 90%). The subgroup meta-analysis showed that strains of Limosilactobacillus fermentum were significantly more effective than strains of Lactiplantibacillus plantarum, Lacticaseibacillus paracasei or Lacticaseibacillus rhamnosus. A longer treatment time and younger treatment age statistically significantly reduced symptoms of atopic dermatitis. The result of this systematic review and meta-analysis shows that certain single-strain probiotic lactobacilli are more successful than others in reducing atopic dermatitis severity in children. Therefore, careful consideration to strain selection, treatment time and the age of the treated patients are important factors in enhancing the effectiveness of reducing atopic dermatitis in children when choosing probiotic single-strain lactobacilli.
More Related Videos
09:32Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
06:06Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease
Published on: May 9, 2022
Related Concept Videos
Probiotics
Development of Human Microbiota
Acne Infection
Clinical Significance of Antibiotic Resistance